
Sixth Philosophy of Cancer Biology Workshop
4 March 2024 | 9 h 00 min - 6 March 2024 | 12 h 30 min

The Sixth Philosophy of Cancer Biology Workshop will be held in Bordeaux, France.
Campus Victoire (in the historic city center) (TBC)
Cancer is one of the main causes of death globally according to the World Health Organization. The biological complexity and heterogeneity of this disease (or group of diseases) make it very difficult to apprehend, control, and cure. We strongly believe that more theoretical and conceptual efforts can benefit cancer research. To this aim we have initiated a series of international workshops whose aim is to gather philosophers, scientists, and medical doctors to discuss theoretical and conceptual challenges that are central to cancer research.
This edition will mostly focus on two topics: (1) the role of the microbiota in cancer development and dissemination, a question that attracts increasing attention but remains challenging to address, (2) metastasis, which is considered as a major challenge for cancer treatment and a leading cause of cancer death, and for which innovative conceptual and theoretical frameworks are needed.
The call for abstract, however, will be open to all emerging conceptual and theoretical issues in cancer research.
Invited speakers:
- Ilaria Elia (KU Leuven, Belgium)
- Andrew Ewald (Johns Hopkins, Baltimore, USA)
- Peter Friedl (Radboud University Nijmegen, Netherland)
- Lucie Laplane (IHPST & Gustave Roussy, Paris, France)
- Cristina Lo Celso (Imperial College London, UK)
- Carlo Maley (Arizona State University, USA)
- Guillaume Montagnac (Gustave Roussy, France)
- Julie Pannequin (Institut de Génomique Fonctionnelle, Montpellier, France)
- Maria Rescigno (Humanitas University, Italia)
- Gregory Sepich-Poore (UCSD, USA)
- Eric Solary (Gustave Roussy, Paris, France)
- Orsolya Vincze (ImmunoConcEpT, CNRS Bordeaux & La Rochelle University, France)
Program
Call for abstracts
The 6th Philosophy of Cancer Biology workshop will be held in Bordeaux, France, from March 4th to March 6th, 2024. Although invited talks will focus on the two topics of cancer microbiome and cancer metastasis, the call for abstracts is open to all emerging conceptual and theoretical issues in cancer research. Selected abstracts will have 15 minutes allocated for their talks followed by 15 minutes of discussion.
The conference is free and open to all researchers.
Young researchers can apply for a grant to help cover the cost of their travel and accommodation. Please contact Thomas Pradeu and Lucie Laplane
Abstracts must be submitted here ( https://forms.gle/CZo357M524Qy5mVu7 ) by Dec 5th. They will be anonymized and evaluated by the scientific committee. Notifications will be sent by December 22nd.
Submissions should contain:
– Title of talk
– Author(s). In case of multiple authors please indicate who will present.
– Institutional affiliation(s)
– Research field
– Position
– Abstract (no longer than 500 words). The abstract must identify a clear biological and/or medical problem and provide an answer to that problem using conceptual, theoretical, and/or philosophical tools. The scientific committee particularly welcomes interdisciplinary submissions as well as submissions that state explicitly what difference their proposal makes to scientific and medical practices.
Organizing committee:
- Lucie Laplane (IHPST & Gustave Roussy, Paris, France) (co-chair)
- Thomas Pradeu (ImmunoConcept, CNRS Bordeaux, France) (co-chair)
- Bertrand Daignan-Fornier (IBGC, CNRS Bordeaux, France)
- Benjamin Spada (ImmunoConcept, CNRS Bordeaux, France)
Scientific committee:
- Bertrand Daignan Fornier (CNRS Bordeaux, France)
- Andrew Ewald (Johns Hopkins, Baltimore, USA)
- Sara Green (University of Copenhagen, Denmark)
- Lucie Laplane (IHPST & Gustave Roussy, Paris, France)
- Maël Lemoine (University of Bordeaux, France)
- Carlo Maley (Arizona State University, USA)
- Violaine Moreau (CNRS Bordeaux, France)
- Julie Pannequin (CNRS, Institut de Génomique Fonctionnelle, Montpellier, France)
- Anya Plutynski (Washington University, USA)
- Thomas Pradeu (CNRS Bordeaux, France)
- Gregory Sepich-Poore (UCSD, USA)
- Vanja Sisirak (CNRS Bordeaux, France)
- Pierre Sujobert (University Claude Bernard, Lyon, France)
- Eric Solary (Gustave Roussy, Paris, France)
Funding
- Moore Foundation (PI: T. Pradeu)